Omada Health, Inc. (OMDA)

Omada Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	209.83	169.8	122.78	89.19
Revenue Growth (YoY)	135.27%	38.29%	37.67%	-
Cost of Revenue	76.93	66.92	52.81	46.39
Gross Profit	132.9	102.88	69.97	42.79
Selling, General & Admin	124.4	110.61	102.23	88.97
Research & Development	36.87	35.92	33.74	26.17
Operating Expenses	161.27	146.53	135.97	115.14
Operating Income	-28.36	-43.65	-66	-72.35
Interest Expense	-4.41	-4.51	-4.71	-4.2
Interest & Investment Income	1.6	0.81	5.78	2.2
Other Non Operating Income (Expenses)	-1.06	0.22	-1.05	1.83
EBT Excluding Unusual Items	-32.24	-47.14	-65.98	-72.52
Other Unusual Items	-	-	-1.54	-
Pretax Income	-32.24	-47.14	-67.51	-72.52
Net Income	-32.24	-47.14	-67.51	-72.52
Net Income to Common	-32.24	-47.14	-67.51	-72.52
Shares Outstanding (Basic)	11	8	7	7
Shares Outstanding (Diluted)	11	8	7	7
Shares Change (YoY)	69.46%	8.89%	4.59%	-
EPS (Basic)	-2.81	-6.10	-9.52	-10.70
EPS (Diluted)	-2.81	-6.10	-9.52	-10.70
Free Cash Flow	-19.54	-34.78	-50.15	-69.7
Free Cash Flow Per Share	-1.70	-4.50	-7.07	-10.28
Gross Margin	63.34%	60.59%	56.99%	47.98%
Operating Margin	-13.52%	-25.71%	-53.75%	-81.12%
Profit Margin	-15.36%	-27.76%	-54.98%	-81.31%
Free Cash Flow Margin	-9.31%	-20.48%	-40.85%	-78.15%
EBITDA	-23.17	-38.85	-61.55	-68.02
EBITDA Margin	-11.04%	-22.88%	-50.13%	-76.27%
D&A For EBITDA	5.19	4.8	4.45	4.33
EBIT	-28.36	-43.65	-66	-72.35
EBIT Margin	-13.52%	-25.71%	-53.75%	-81.12%
Revenue as Reported	209.83	169.8	122.78	89.19
Advertising Expenses	-	0.5	0.8	0.7

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q